JIUYUAN GENE (02566) · Company profile · Eqvero

JIUYUAN GENE

02566HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	1.31 bn CNY	1.37 bn CNY	1.29 bn CNY	1.13 bn CNY	1.31 bn CNY
Cost of revenue	213.44 m CNY	250.57 m CNY	260.6 m CNY	235.37 m CNY	332.6 m CNY
Research and development expense	123.66 m CNY	108.9 m CNY	127.76 m CNY	158.31 m CNY	132.63 m CNY
Selling, general and administrative expense	785.77 m CNY	808.38 m CNY	723.62 m CNY	649.02 m CNY	686.08 m CNY
Operating profit after depreciation	141.3 m CNY	157.05 m CNY	137.42 m CNY	45.91 m CNY	130.28 m CNY
Operating profit before depreciation	180.1 m CNY	193.99 m CNY	173.55 m CNY	81.68 m CNY	154.52 m CNY
EBIT	141.3 m CNY	157.05 m CNY	137.42 m CNY	45.91 m CNY	130.28 m CNY
EBITDA	180.1 m CNY	193.99 m CNY	173.55 m CNY	81.68 m CNY	154.52 m CNY
Interest expense	5.66 m CNY	7.15 m CNY	9.39 m CNY	9.04 m CNY	9.72 m CNY
Profit before tax	161.52 m CNY	168.63 m CNY	134.93 m CNY	51.42 m CNY	127.54 m CNY
Income tax expense	23.12 m CNY	30.03 m CNY	15.16 m CNY	-8.45 m CNY	8.12 m CNY
Income before extraordinary items	138.41 m CNY	138.6 m CNY	119.78 m CNY	59.87 m CNY	119.41 m CNY
Common dividends	13.77 m CNY	13.74 m CNY	—	—	12 m CNY
Total dividends	13.77 m CNY	13.74 m CNY	—	—	12 m CNY

Quotes are end-of-day data. Content is for research purposes and is not investment advice.